- Why health systems are wasting nurses’ research potential: Penn Nursing scholar
- GLP-1 drugmakers step in to promote Medicare’s Bridge program
- White House’s grant overhaul proposal: Where things stand
- Atrium’s innovation district generates $224M in year 1
- 7 health systems outsourcing RCM functions
- The private equity race regulators haven’t caught up to
- New Mexico hospital names assistant CEO
- Weill Cornell taps new chair of surgery, surgeon-in-chief
- OU Health’s new CEO on well-timed questions, what he won’t delegate and what’s next
- Christus Health plans $28M micro-hospital
- The state-by-state battle over anesthesia time caps
- 4 recent hospital, health system CFO moves in 2026
- Oregon hospital aims to fast-track merger to ‘avoid insolvency’
- What happens to ASC contracts when a payer gets absorbed
- What will make or break the future of DSO success
- Dentistry reaches inflection point with AI
- Former UPMC cardiologist drops suit over CEO’s device company ties
- Dental assistant pay vs. cost of living by state
- South Carolina cites behavioral health facility over missing correction plan
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- GI consolidation’s new era: 5 deals to know
- The GI procedure cuts in CMS’ pay proposal: 5 things to know
- ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
- Washington restricts spit hood use in state psychiatric facilities
- Remarks at the Society for Corporate Governance Conference
- Maryland health system receives $10M gift to construct ASC
- 1-800-Dentist faces class-action lawsuit over data breach
- Staten Island hospital debuts mobile behavioral health program for youth
- A lifeline for the anesthesia workforce?
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- Tennessee physician sentenced for reusing medical devices in $41M fraud scheme
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Telehealth ex-CEO sentenced in Adderall fraud case: 5 things to know
- Oklahoma awards 4 behavioral health clinic contracts
- The key to patient trust in dentistry
- Good news, bad news for the dental workforce
- 7 behavioral health layoffs to know | 2026
- 200+ dentists making headlines halfway through 2026
- How students are paying for dental school
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- U of Kentucky dental dean receives top educator award
- The dividing line between private practices and DSOs
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- 36 behavioral health executive moves to know
- Delaware establishes statewide opioid treatment guidance for EDs
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Catalent sells UK facility to Codis, expands Nanoscope partnership
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Nonprofit-private equity joint ventures worth scrutiny, PESP report says
- Lenz Therapeutics rolls out telehealth offering for Vizz prescription eye drops
- American Heart Association joins social network Roon for medical research collaboration
- Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Ascension plans to acquire independent system Williamson Health for nearly $1B
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Novartis dismisses 322 more staffers based out of US headquarters
- Allegheny Health Network acquires Heritage Valley Health System
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
- FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
- Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
- Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
- Skin quality driving widespread quality-of-life issues: survey
- AI care partner Heidi puts a spin on pharma ad tropes in new campaign to relieve 'side effects'
- Handspring Health lands $19M series B to expand behavioral health model for youth
- Nonprofit hospitals are embracing high-risk, high-reward investment portfolios. Is that a problem?
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Teladoc Health inks multi-year virtual care deal with National Basketball Players Association
- FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Regulatory tracker: AbbVie, Genmab's blood cancer bispecific expands label in EU
- Can A Popular Muscle Supplement Help Treat Depression?
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
Erica G. Schwartz is a retired rear admiral in the U.S. Public Health Service Commissioned Corps who was Deputy Surgeon General from January 2019 to April 2021:
Trump nominates former deputy surgeon general as CDC director
By Yasmeen Abutaleb and Julie Steenhuysen - April 16, 2026Summary
- Position has been open since Susan Monarez was fired last year
- Schwartz has been praised by former public health officials
- Nominated healthcare executive Sean Slovenski as deputy director
WASHINGTON, April 16 (Reuters) - U.S. President Donald Trump said on Thursday he would nominate Erica Schwartz, who had served as deputy surgeon general during the COVID-19 pandemic, to become director of the Centers for Disease Control and Prevention following multiple leadership shakeups at the health agency.
Schwartz, who served during Trump's first term, was involved in the federal COVID response, helping to coordinate national preparedness and public health efforts.
The nomination represents a far more traditional pick for the embattled health agency, as the White House seeks to focus on more popular issues such as lowering drug prices and food safety, rather than Health Secretary Robert F. Kennedy Jr.'s controversial vaccine policies with Republicans bracing for a difficult November midterm election. At a pair of congressional hearings on Thursday, Kennedy largely avoided questions about vaccines.
Trump, in a post on Truth Social, also said he was naming healthcare executive Sean Slovenski as CDC deputy director and chief operating officer, Texas Health Commissioner Jen Shuford as CDC deputy director and chief medical officer and FDA official Sara Brenner as senior counselor for public health to Kennedy.
The nominations come after a Massachusetts judge blocked key parts of Kennedy's effort to reshape U.S. vaccine policy, including a move to reduce the number of shots routinely recommended for children, and his overhaul of a CDC advisory committee on inoculations.
If approved, Schwartz would lead the Atlanta-based agency, which tracks and responds to domestic and foreign threats to public health. The CDC director traditionally has the final say on U.S. vaccine policy.
She would report to Kennedy, who has long questioned the safety of vaccines, contrary to established science.
Trump fired CDC Director Susan Monarez last August over her objections to vaccine policy changes planned by Kennedy. Her position was filled by two acting directors: Health and Human Services Deputy Secretary Jim O'Neill, who was succeeded in February by Jay Bhattacharya, the director of the U.S. National Institutes of Health.
MORE TRADITIONAL CANDIDATES
Schwartz, who does not have a widely publicized position on vaccines, has been praised by former public health officials who have been critical of Kennedy's vaccine policies.
Demetre Daskalakis, former CDC director of the National Center for Immunization and Respiratory Diseases who resigned after Monarez's firing, said Schwartz showed "good leadership" during the COVID response and has a "proven track record... notably with pandemic preparedness."
Polls have shown most voters disapprove of Kennedy's moves to overhaul the childhood vaccination schedule.
The White House has pushed for more traditional candidates for top agency roles after Kennedy handpicked a slate of controversial political appointees who have undermined trust in vaccines, according to sources familiar with the discussions.
Close Kennedy ally and vaccine injury lawyer Aaron Siri was critical of the nomination.
"Her long track record of directly issuing rights-crushing civilian and military vaccine mandates, including mandating injection of smallpox, anthrax, and flu vaccines into U.S. Forces, and disciplining those that refused, reflects she lacks the basic ethics and morals to lead the CDC," Siri said. "This agency does not need another cheerleader for industry."
The Erica Schwartz nomination was actually Secretary Kennedy's:
https://thehill.com/policy/healthcare/5841154-kennedy-trump-cdc-nominee/
RFK Jr. says he did not speak to Trump about CDC nominee
By Nathaniel Weixel - April 21, 2026Health Secretary Robert F. Kennedy Jr. did not speak to President Trump about nominating Erica Schwartz to lead the Centers for Disease Control and Prevention, he told lawmakers Tuesday.
Kennedy told a House Energy and Commerce subcommittee that he met with Schwartz on “multiple occasions” prior to her being tapped as the new nominee, including to discuss her views on vaccinations.
But Kennedy said it was HHS chief counselor Chris Klomp who spoke with Trump about the nomination. He also said HHS suggested Schwartz as a candidate to the White House.
Klomp was elevated to the agency’s No. 2 spot in February, reportedly to help the White House instill a stabilizing force and message discipline at HHS ahead of the midterm elections.
Schwartz, who served as deputy surgeon general during the first Trump administration and spent much of her career in health roles in the U.S. military, has no public ties to the anti-vaccine movement.
Public health leaders and advocates breathed sighs of relief when Trump announced her as the nominee late last week, and her nomination was seen as a clear sign that the administration is putting pressure on Kennedy to sideline his controversial vaccine policies due to political concerns in an election year.
But there is concern that Schwartz will need to be granted full autonomy from Kennedy to succeed in steadying the CDC and reinforcing its reputation as the leading scientific and public health agency.
Her predecessor, Susan Monarez, boasted similar public health credentials but was fired after less than a month on the job because she clashed with Kennedy over vaccine moves.
Under questioning from Rep. Raul Ruiz (D-Calif.), Kennedy declined to commit to implementing any vaccine guidance issued by Schwartz.
“You’ll probably fire her” like Monarez, Ruiz said, “because you will not accept recommendations based on science.”
Kennedy then denied he had been sidelined by the White House.
“That’s not true,” Kennedy said. “You’re not getting truths.”
“How does that make you feel, Mr. Secretary?” Ruiz continued. “You must be aware of that. It must be nerve-wracking, especially after AG [Pam] Bondi, and Secretaries [Kristi] Noem and [Lori] Chavez-Deremer were fired for making the president look bad.”
“You’re making stuff up,” Kennedy shot back.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























